Carteolol contraindications: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Carteolol}} {{CMG}}; {{AE}} {{SS}} ==Contraindications== Ocupress Ophthalmic Solution is contraindicated in those individuals with bronchial asthma or with a ...")
 
(Redirected page to Carteolol#Contraindications)
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Carteolol#Contraindications]]
{{Carteolol}}
{{CMG}}; {{AE}} {{SS}}
 
==Contraindications==
Ocupress Ophthalmic Solution is contraindicated in those individuals with [[bronchial asthma]] or with a history of [[bronchial asthma]], or severe [[chronic obstructive pulmonary disease]] (see WARNINGS); [[sinus bradycardia]]; second- and third-degree [[atrioventricular block]]; overt cardiac failure (see WARNINGS); cardiogenic shock; or hypersensitivity to any component of this product.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ZEBETA (BISOPROLOL FUMARATE) TABLET [DURAMED PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a11548a0-9c0f-4729-907c-75d8f99a6c85 | publisher =  | date =  | accessdate = 4 February 2014 }}</ref>
 
 
 
 
==References==
 
{{Reflist|2}}
 
[[Category:Beta blockers]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 01:27, 22 July 2014